Table 1.
plp1tg/− mice | NRG1-erbB4 transgenic mice | Nogo-A deficient mice | CPZ-fed mice | |
---|---|---|---|---|
Altered myelin structure | — | √ | No data | √ |
OL loss | No data | √ | No data | √ |
Decreased axonal conductance | √ | √ | No data | No data |
Dopamine level | No data | No data | ↓ | ↑ |
D2 receptors | No data | ↑ | ↓ | No data |
NMDA receptors | No data | ↓ | No data | No data |
Hyperactivity | No data | √ | No data | √ |
Anxiety-like behaviors | √ | √ | √ | √ |
Disrupted PPI | √ | √ | √ | √ |
Spatial learning deficit | √ | √ | No data | √ |
Working memory deficit | √ | √ | No data | √ |
Impaired social activities | No data | √ | — | √ |
Response to antipsychotics | No data | √ | No data | √ |